Table S1. Epitope mapping of HER3-VIA using spotted 15-mer peptide arrays. Epitope mapping was performed using spotted peptide arrays of 15-mer peptides overlapping by four amino acids representing the full length of the human HER3 protein. HER3 peptides were coated onto cellulose membranes using a Spot Robot ASP 222 (AbiMed) and epitope mapping of HER3-VIA (1:100 dilution in saline) was performed as described [26]. (PDF 36 kb
Figure S1. Prophylactic autophagosome vaccination did not alter CD3 + CD4+ or CD3 + CD4 + FOXP3+ inf...
Figure S3. Cytokines/chemokines in the sera of 4T1 tumor-bearing Balb/c mice treated with svL4 at do...
CD3 levels in 4T1 tumors grown in wild-type BALB/c mice. Samples were from the experiment shown in F...
Figure S1. Flow cytometric detection of HER3 on human breast cancer cell lines with anti-HER3 monocl...
Figure S2. Flow cytometric detection of cell surface EGFR/HER2/HER3 expression after treatment with ...
Figure S1. NF-κB activity was measured using cancer cell lysates to assess TLR4-expressing tumor cel...
Figure S3. Combinatory treatment with HER3 siRNA and trastuzumab is useful for overcoming trastuzuma...
Figure S1 Generation of a murine EMT6-hHER2 breast cancer cell line. A, Human-HER2 expression in EMT...
Figure S1. RTK expression and ERBB2-targeting antibody response in breast cancer cell lines. Figure ...
Figure S1. Cath-D expression in different BC subtypes. Total cath-D expression was determined in 159...
Table S1. Summary of prognostic/predictive value of tumor infiltrating lymphocytes (TILs) in HER2+ b...
Figure S1. Schematic representation of the therapeutic strategy. Figure S2. Schematic representation...
Figure S5. Reciprocal ceRNA activity between HER2 and HER3 3âUTR. HER2 3âUTR-luciferase reporter...
Immunoprecipitation of HSP90 from xenograft tumor lysates using HCAb2. RIPA lysates of xenograft tum...
Figure S1. The PI3K/AKT pathway significantly contributes to the ligand-driven HER2 signaling activi...
Figure S1. Prophylactic autophagosome vaccination did not alter CD3 + CD4+ or CD3 + CD4 + FOXP3+ inf...
Figure S3. Cytokines/chemokines in the sera of 4T1 tumor-bearing Balb/c mice treated with svL4 at do...
CD3 levels in 4T1 tumors grown in wild-type BALB/c mice. Samples were from the experiment shown in F...
Figure S1. Flow cytometric detection of HER3 on human breast cancer cell lines with anti-HER3 monocl...
Figure S2. Flow cytometric detection of cell surface EGFR/HER2/HER3 expression after treatment with ...
Figure S1. NF-κB activity was measured using cancer cell lysates to assess TLR4-expressing tumor cel...
Figure S3. Combinatory treatment with HER3 siRNA and trastuzumab is useful for overcoming trastuzuma...
Figure S1 Generation of a murine EMT6-hHER2 breast cancer cell line. A, Human-HER2 expression in EMT...
Figure S1. RTK expression and ERBB2-targeting antibody response in breast cancer cell lines. Figure ...
Figure S1. Cath-D expression in different BC subtypes. Total cath-D expression was determined in 159...
Table S1. Summary of prognostic/predictive value of tumor infiltrating lymphocytes (TILs) in HER2+ b...
Figure S1. Schematic representation of the therapeutic strategy. Figure S2. Schematic representation...
Figure S5. Reciprocal ceRNA activity between HER2 and HER3 3âUTR. HER2 3âUTR-luciferase reporter...
Immunoprecipitation of HSP90 from xenograft tumor lysates using HCAb2. RIPA lysates of xenograft tum...
Figure S1. The PI3K/AKT pathway significantly contributes to the ligand-driven HER2 signaling activi...
Figure S1. Prophylactic autophagosome vaccination did not alter CD3 + CD4+ or CD3 + CD4 + FOXP3+ inf...
Figure S3. Cytokines/chemokines in the sera of 4T1 tumor-bearing Balb/c mice treated with svL4 at do...
CD3 levels in 4T1 tumors grown in wild-type BALB/c mice. Samples were from the experiment shown in F...